NCT05520268 · RECRUITING

Efficacy of Music Therapy and Digital Music Rehabilitation in Dementia

This trial is testing whether music therapy — either delivered by a therapist in person or through a digital app at home — can help people already living with dementia. Researchers are measuring how well each approach works on symptoms like mood, behavior, and cognition. This is a Phase N/A trial, meaning it sits outside the standard phase numbering — it is evaluating a behavioral approach rather than a drug, and it is being run in Finland.

You may qualify if

  • Diagnosed dementia (according to International Classification of Diseases [ICD] criteria), which is mild [Clinical Dementia Rating (CDR) score: 0.5-1, Global Deterioration Scale (GDS) score: 3-4], moderate (CDR: 2, GDS: 4-6), or severe (CDR: 3, GDS: 6-7) dementia
  • Age ≥ 60 years
  • Finnish-speaking (or bilingual; the study is performed in Finnish)
  • Stable physical and somatic condition (no major changes in psychotropic medication during the last 3 months)
  • Physically and cognitively able to take part in the intervention and assessments.

You're excluded if

  • Prior severe psychiatric illness or substance abuse
  • Major hearing or visual impairment

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-02-06

View full record on ClinicalTrials.gov

All APOE4 clinical trials